Orginal Article |
|
|
|
|
Advance in Large-Scale Culture of Hybridoma Cells in Vitro |
Jing-jing SUN,Wei-wei ZHOU,Lei-ming ZHOU,Qiao-hui ZHAO(),Gui-lin LI |
Zhengzhou Autobio Diagnostic Co,LTD,Zhengzhou 450016,China |
|
|
Abstract Monoclonal antibodies have shown great value in the field of biology and medical research. They are new reagents in immunoassays and are the guided weapons for biological therapy. As a diagnostic reagent in vitro, monoclonal antibody can give full play to its advantages, such as good specificity, high sensitivity, and more convenient for quality control, which is conducive to standardization .Traditionally,mouse ascites were used to prepare monoclonal antibodies. Now monoclonal antibodies are also being developed in large-scale cultures of hybridoma cells in vitro. In particular, the needs of monoclonal antibodies in the diagnosis and treatment of diseases have further promoted the development of invitro culture and production techniques for hybridoma cells. Due to the semi-adherent nature of the hybridoma cells, both in suspension and adherent culture, large-scale invitro culture of hybridoma cells can be performed. This article reviews the invitro culture techniques of hybridoma cells, including hollow fiber cell culture system and bioreactor cell culture sysytem, as well as the optimization of different culture methods.
|
Received: 28 April 2018
Published: 09 November 2018
|
|
Corresponding Authors:
Qiao-hui ZHAO
E-mail: zhaoqiaohui@autobio.com.cn
|
|
|
[1] |
张元兴, 魏明旺, 董志峰 . 杂交瘤细胞的大量培养. 生物工程进展, 1997,17(5):54-60.
|
|
|
[1] |
Zhang Y X, Wei M W, Dong Z F . Large scale culture of hybridoma cells. Advances in Environmental Bioengineering, 1997,17(5):54-60.
|
|
|
[2] |
辛彦斌, 薛小平, 朱美福 , 等. 杂交瘤细胞体外大量培养研究的进展, 细胞与分子免疫学杂志, 1990,6(2):63-66.
|
|
|
[2] |
Xin Y B, Xue X P, Zhu M F , et al. Advances of large-scale culture of hybridoma cells in vitro. Journal of Cellular and Molecular Immunology, 1990,6(2):63-66.
|
|
|
[3] |
Carson K L . Flexibility the guiding principle for antibody manufacturing. Nat Biotechnol. 2005,23(9):1054-1058.
doi: 10.1038/nbt0905-1054
pmid: 16151390
|
|
|
[4] |
Rodrigues M E, Costa A R, Henriques M , et al. Technological progresses in monoclonal antibody production systems. Biotechnol Prog, 2010,26(2):332-351.
doi: 10.1002/btpr.348
pmid: 20043321
|
|
|
[5] |
Heine H, Biselli M, Wandrey C . High cell density cultivation of hybridoma cells:Spin filter vs immobilized culture. Animal Cell Technology:Products from Cells, Cells as Products, 1999, 83-85.
doi: 10.1007/0-306-46875-1_18
|
|
|
[6] |
Vermasvuori R, Hurme M . Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes. Biotechnology Progress, 2011,27(6):1588-1598.
doi: 10.1002/btpr.676
pmid: 21954092
|
|
|
[7] |
李峻城, 姜述德 . 中空纤维细胞培养技术.国外医学:预防. 诊断, 1989 ( 1):1-4.
|
|
|
[7] |
Li J C, Jiang S D . Hollow fiber cell culture technology.Foreign Medicine:Prevention. Diagnosis, 1989 ( 1):1-4.
|
|
|
[8] |
John J S. 中空纤维细胞培养的新进展. 中国实验室, 2005,4:21-27.
|
|
|
[8] |
John J S . New developments in hollow-fiber cell culture. China Laboratory, 2005,4:21-27.
|
|
|
[9] |
Jain E, Kumar A . Upstream processes in antibody production:Evaluation of critical parameters, Biotechnology Advances. 2008,26(1):46-72.
doi: 10.1016/j.biotechadv.2007.09.004
|
|
|
[10] |
Legazpi L, Laca A, Collado S , et al. Diffusion and inhibition processes in a hollow-fiber membrane bioreactor for hybridoma culture.Development of a mathematical model. Chem Biochem Eng Q, 2016,30(2):213-225.
doi: 10.15255/CABEQ
|
|
|
[11] |
Van E R, Adorf M, Sommeren A P , et al. Monitoring of the production of monoclonal antibodies by hybridomas.Part I:Long-term cultivation in hollow fibre bioreactors using serum-free medium. Journal of Biotechnolog, 1991,20(3) : 249-261.
doi: 10.1016/0168-1656(91)90298-A
pmid: 1367572
|
|
|
[12] |
Jackson L R, Trudel L J, Fox J G , et al. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production. Journal of Immunological Methods, 1996,189(2):217-231.
doi: 10.1016/0022-1759(95)00251-0
pmid: 8613673
|
|
|
[13] |
Takenouchi S, Sugahara T . Lactate dehydrogenase enhances immunoglobulin production by human hybridoma and human peripheral blood lymphocytes, Cytotechnology, 2003,42(3):133-143.
doi: 10.1023/B:CYTO.0000015838.06536.de
pmid: 19002935
|
|
|
[14] |
Jain E, Kumar A . Upstream processes in antibody production:Evaluation of critical parameters. Biotechnology Advances, 2008,26(1):46-72.
|
|
|
[15] |
Ayyildiz-Tamis D, Nalbantsoy A, Elibol M , et al. Effect of operating conditions in production of diagnostic salmonella enteritidis O-antigen-specific monoclonal antibody in different bioreactor systems. Appl Biochem Biotechnol, 2014,172(1):224-236.
doi: 10.1007/s12010-013-0532-4
pmid: 24068476
|
|
|
[16] |
Chen Z L, Wu B C, Liu H , et al. Temperature shift as a process optimization step for the production of pro-urokinase by a recombinant Chinese hamster ovary cell line in high-density perfusion culture. J Biosci Bioeng, 2004,97(4):239-243.
doi: 10.1016/S1389-1723(04)70198-X
pmid: 16233622
|
|
|
[17] |
Ogawa T, Kamihira M, Yoshida H , et al. Effect of dissolved-oxygen concentration on monoclonal-antibody production in hybridoma cell-cultures. J Ferment Bioeng, 1992,74(6):372-378.
doi: 10.1016/0922-338X(92)90034-R
|
|
|
[18] |
Trummer E, Fauland K, Seidinger S , et al. Process parameter shifting: Part I.Effect of DOT,pH,and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors. Biotechnol Bioeng, 2006,94(6):1033-1044.
doi: 10.1002/(ISSN)1097-0290
|
|
|
[19] |
Abu-Reesh I, Kargi F . Biological responses of hybridoma cells to hydrodynamic shear in an agitated bioreactor. Enzyme Microb Technol, 1991,13(11):913-919.
doi: 10.1016/0141-0229(91)90108-M
pmid: 1368002
|
|
|
[20] |
Lu F, Toh P C, Burnett I , et al. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development. Biotechnol Bioeng, 2013,110(1):191-205.
doi: 10.1002/bit.24602
|
|
|
[21] |
Read E K, Bradley S A, Smitka T A , et al. Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture. Biotechnol Prog, 2013,29(3):745-753.
doi: 10.1002/btpr.1728
pmid: 23606649
|
|
|
[22] |
Rouiller Y, Perilleux A, Marsaut M , et al. Effect of hydrocortisone on the production and glycosylation of anFc-fusion protein in CHO cell cultures. Biotechnol Prog, 2012,28(3):803-813.
doi: 10.1002/btpr.1530
pmid: 22535835
|
|
|
[23] |
Madhavarao C N, Agarabi C D, Wong L , et al. Evaluation of butyrateinduced production of a mannose-6-phosphorylated therapeutic enzyme using parallel bioreactors. Biotechnol Appl Biochem, 2014,61(2):184-192.
doi: 10.1002/bab.1151
pmid: 24033810
|
|
|
[24] |
Banerjee A, Ma N N, Ramasubramanyan N . Designing in quality: Approaches to defining the design space for a monoclonal antibodyprocess. Biopharm Int, 2010,23(5):26-40.
|
|
|
[25] |
Chee Furng Wong D, Tin Kam Wong K, Tang Goh L , et al. Impact of dynamic online fed-batch strategies on metabolism,productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng, 2005,89(2):164-177.
doi: 10.1002/bit.20317
pmid: 15593097
|
|
|
[26] |
Hasegawa H, Wendling J, He F , et al. In vivo crystallization of human IgG in the endoplasmic reticulum of engineered Chinese hamster ovary (CHO) cells. J Biol Chem, 2011,286(22):19917-19931.
doi: 10.1074/jbc.M110.204362
pmid: 3103367
|
|
|
[27] |
Handa A, Emery A N, Spier R E . On the evaluation of gasliquid interfacial effects on hybridoma viability in bubble column bioreactors. Developments in Biological Standardization, 1987,66(4):241-253.
doi: 10.1016/0141-0229(89)90097-5
pmid: 3582753
|
|
|
[28] |
Butler M, Huzel N . The effect of fatty acids on hybridoma cell growth and antibody productivity in serum-free cultures. Journal of Biotechnology, 1995,39(2):165-173.
doi: 10.1016/0168-1656(95)00017-K
|
|
|
[29] |
Agarabi C D, Schiel J E, Lute S C , et al. Bioreactor process parameter screening utilizing a plackett-burman design for a model monoclonal antibody.[J] Pharm Sci. 2015,104(6):1919-1928.
doi: 10.1002/jps.24420
pmid: 25762022
|
|
|
[30] |
Zhang L, Shen H, Zhang Y X . Fed-batch culture of hybridoma cells in serum-free medium using an optimized feeding strategy, Journal of Chemical Technology & Biotechnology. 2004,79(2):171-181.
doi: 10.1002/jctb.940
|
|
|
[31] |
Jo E C, Park H J, Kim D I , et al. Repeated fed-batch culture of hybridoma cells in nutrient-fortified high-density medium. Biotechnology and Bioengineering, 1993,42(10):1229-1237.
doi: 10.1002/bit.260421013
pmid: 18609672
|
|
|
[32] |
郭纪元 . CHO DG44稳定细胞株无血清培养基的研发与优化. 厦门:厦门大学, 2014.
|
|
|
[32] |
Guo J Y . Development and optimization of the serum-free medium for CHO DG44 stable cell line. Xiamen:Xiamen University, 2014.
|
|
|
[33] |
刘美 . GS-CHO细胞培养工艺优化. 哈尔滨:东北农业大学, 2012.
|
|
|
[33] |
Liu M . Process optimization for GS-CHO cells culture. Harbin: Northeast Agricultural University, 2012.
|
|
|
[34] |
蒋金龙 . 基于脂类代谢的DHFR-CHO细胞培养过程开发与优化. 上海:华东理工大学, 2015.
doi: 10.15889/j.issn.1002-1302.2016.01.008
|
|
|
[34] |
Jiang J L . Process development and optimization for DHFR-CHO cells based on lipid metabolism. Shanghai:East China University of Science and Technology, 2015.
doi: 10.15889/j.issn.1002-1302.2016.01.008
|
|
|
[35] |
Xie L, Wang D I . Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor. Cytotechnology, 1994,15(1):17-29.
doi: 10.1007/BF00762376
pmid: 7765929
|
|
|
[36] |
Xie L, Wang D I . Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies. Biotechnology and Bioengineering, 1994,43(11):1175-1189.
doi: 10.1002/bit.21160
pmid: 18615531
|
|
|
[37] |
Xie L, Wang D I . Different medium design concepts and feeding strategies. Biotechnology and Bioengineering, 1993,95(2):271-284.
|
|
|
[38] |
Shibuya K, Haga R, Namba M . A serum substitute for fed-batch culturing of hybridoma cells. Cytotechnology, 2008,57(2):187-197.
doi: 10.1007/s10616-008-9155-y
pmid: 2553663
|
|
|
[39] |
Gek Kee Chua . Development of a low serum medium for the production of monoclonal antibody against congenital adrenal hyperplasia by hybridoma culture. Preparative Biochemistry and Biotechnology, 2016,46(7):679-689.
doi: 10.1080/10826068.2015.1135450
pmid: 26760282
|
|
|
[40] |
Cherlet M, Marc A . Stimulation of monoclonal antibody production of hybridoma cells by butyrate: evaluation of a feeding strategy and characterization of cell behaviour. Cytotechnology, 2000,32(1):17-29.
doi: 10.1023/A:1008069523163
pmid: 3449445
|
|
|
[41] |
Rokni M, Razavi A R, Shokri F , et al. Enhancement of monoclonal antibody production after single and combination treatment of the hybridoma cells with all-trans retinoic acidand docosahexaenoic acid: An in vitro and in vivo study. International Immunopharmacology. 2018,59:295-300.
doi: 10.1016/j.intimp.2018.03.008
pmid: 29677631
|
|
|
[42] |
Konno Y, Aoki M, Takagishi M , et al. Enhancement of antibody production by the addition of coenzyme-Q (10). Cytotechnology, 2011,63(2):163-170.
doi: 10.1007/s10616-010-9330-9
pmid: 3080474
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|